To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
- Investigator
- Thomas M Beaver
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Cardiovascular Surgeon
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic…
227 publications
2025
JACC. Case reports
PubMed • Publisher's site2025
Multimedia manual of cardiothoracic surgery : MMCTS
PubMed • Publisher's site2025
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed • Publisher's site2025
Future cardiology
PubMed • Publisher's site2025
Innovations (Philadelphia, Pa.)
PubMed • Publisher's site